CTKB

NASDAQStock

Cytek Biosciences, Inc.

$4.01+0.01 (+0.25%)

52-Week Range

$2.42

$5.88

Key Stats

Market Cap

515.5M

P/E Ratio

—

Dividend Yield

—

Beta

1.31

Volume

607.3K

Avg Volume

851.4K

Performance

-4.08%

-13.79%

+1.01%

YTD

-18.70%

-4.76%

-58.76%

-78.68%

Price Chart

ETF Exposure

CTKB is held by 87 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SMMD	iShares Russell 2500 ETF	0.00%	42,183	$175K	$2.28B	0.23%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	307,535	$1.2M	$40.55B	0.17%
DFSU	Dimensional - US Sustainability Core 1 ETF	0.00%	10,300	$41K	$1.87B	0.15%
HDG	ProShares - Hedge Replication ETF	0.00%	131	$524	$23.2M	0.95%
AVUS	Avantis U.S. Equity ETF	0.00%	11,447	$58K	$10.96B	0.15%
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	6,700	$27K	$2.68B	0.14%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	26,782	$107K	$10.37B	0.12%
DFSV	Dimensional - US Small Cap Value ETF	0.00%	18,244	$73K	$6.63B	0.30%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	114,344	$476K	$80.22B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	28,046	$117K	$17.30B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	61,494	$252K	$37.50B	0.03%
SPTM	State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF	0.00%	16,422	$66K	$11.88B	0.03%
VLU	State Street SPDR S&P 1500 Value Tilt ETF	0.00%	1,301	$5K	$609.7M	0.12%
VTHR	Vanguard Russell 3000 ETF	0.00%	9,813	$49K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	3,411,248	$17.1M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	17,942	$121K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,547	$10K	$1.29B	0.17%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	6,722,605	$24K	$3.91B	0.07%
AOA	iShares Core 80/20 Aggressive Allocation ETF	0.00%	2,479	$10K	$2.84B	0.19%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.00%	244	$1K	$725.0M	0.20%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.00%	747	$3K	$1.67B	0.20%
AOR	iShares Core 60/40 Balanced Allocation ETF	0.00%	2,159	$9K	$3.23B	0.20%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	25	$104	$803.1M	0.23%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	10	$41	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	33	$135	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	56	$231	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	64	$266	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	76	$315	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	63	$262	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	42	$173	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	32	$131	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	14	$58	$9.3M	0.12%
MMTM	State Street SPDR S&P 1500 Momentum Tilt ETF	0.00%	112	$464	$163.7M	0.12%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	167	$1K	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	5,991	$41K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	28	$196	$337.7M	0.32%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	114,344	$37K	$14.63B	0.20%

PreviousPage 2 of 2

About CTKB ETF Exposure

Cytek Biosciences, Inc. (CTKB) is held by 87 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 515.5M, CTKB is a widely held institutional stock. The stock currently trades at $4.01. Investors can gain exposure to CTKB through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CTKB, sorted by portfolio weight.